New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 2, 2004
app pub date -
Jun 1, 2004
filing date -
Jul 25, 2001
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention relates to dendritic cells irreversibly triggered to maturation, which are CD14 positive, which express MHC class I with a median fluorescence intensity less than about 1500 and CD86 with a median fluorescence intensity less than about 500, as determined by immunofluorescence staining and flow cytometry analysis.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully